Ovoca Bio | OVG - Assets


Ovoca Bio reported EUR2.07M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 342.13M 7.53M Sep/2026
Alaunos Therapeutics USD 1.52M 367K Jun/2026
ALKERMES USD 4.44B 42.4M Sep/2026
Avita Medical AUD 47.78M 8.62M Jun/2026
Dianthus Therapeutics USD 1.28B 62.98M Sep/2026
Great Western Mining Corporation EUR 9.37M 539.69K Dec/2025
Ionis Pharmaceuticals USD 2.91B 81.91M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 13.47B 2.51B Sep/2026
Organon & Co USD 13.4B 223M Sep/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Revvity USD 11.49B 555.49M Sep/2026
Tectonic Therapeutic USD 237.03M 9.54M Jun/2026
Viatris USD 34.68B 362M Sep/2026
Xeris Pharmaceuticals USD 423.22M 11.31M Sep/2026